Literature DB >> 31192534

A structured programme to withdraw antipsychotics among adults with intellectual disabilities: The Cornwall experience.

Rohit Shankar1,2, Mike Wilcock3, Shoumitro Deb4, Rebecca Goodey1, Eve Corson1, Charlotte Pretorius1, Georgina Praed3, Amanda Pell3, Dee Vujkovic1, Ellen Wilkinson1, Richard Laugharne1, Sharon Axby1, Rory Sheehan5, Regi Alexander6.   

Abstract

BACKGROUND: Antipsychotic medications are used among 19%-58% of adults with intellectual disabilities to manage challenging behaviour against the NICE guideline recommendations. Studies show that it is possible to completely withdraw antipsychotics in about one third of adults with intellectual disabilities and a dose reduction of 50% or more in another third.
METHOD: In Cornwall, over three years the present authors developed a structured pathway to withdraw antipsychotics among adults with intellectual disabilities which involved people with intellectual disabilities and their carers, GPs, community learning disability team members and pharmacists.
RESULTS: The present authors managed to withdraw antipsychotics totally among 46.5% (33/71) and reduced over 50% of dosage in another 11.3% (8/71) of adults with intellectual disabilities. At three months follow-up no one required hospital admission or change in placement.
CONCLUSION: It is possible to withdraw/reduce antipsychotics in a high proportion of adults with intellectual disabilities if a concerted effort is made involving all stakeholders from the outset.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  adults; antipsychotics withdrawal; challenging behaviour; intellectual disabilities; structured pathway

Mesh:

Substances:

Year:  2019        PMID: 31192534     DOI: 10.1111/jar.12635

Source DB:  PubMed          Journal:  J Appl Res Intellect Disabil        ISSN: 1360-2322


  4 in total

1.  A structured medication review tool to promote psychotropic medication optimisation for adults with intellectual disability: feasibility study.

Authors:  Rory Sheehan; André Strydom; Louise Marston; Nicola Morant; Federico Fiori; Paramala Santosh; Angela Hassiotis
Journal:  BMJ Open       Date:  2019-12-15       Impact factor: 2.692

2.  Management of psychotropic medications in adults with intellectual disability: a scoping review.

Authors:  Ashley Costello; Eithne Hudson; Susan Morrissey; Drona Sharma; Dervla Kelly; Owen Doody
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

3.  UK psychiatrists' experience of withdrawal of antipsychotics prescribed for challenging behaviours in adults with intellectual disabilities and/or autism.

Authors:  Shoumitro Deb; Tom Nancarrow; Bharati Limbu; Rory Sheehan; Mike Wilcock; David Branford; Ken Courtenay; Bhathika Perera; Rohit Shankar
Journal:  BJPsych Open       Date:  2020-09-17

4.  Short-Term Psycho-Education for Caregivers to Reduce Overmedication of People with Intellectual Disabilities (SPECTROM): Development and Field Testing.

Authors:  Shoumitro Shoumi Deb; Bharati Limbu; Gemma Unwin; Linda Woodcock; Vivien Cooper; Michael Fullerton
Journal:  Int J Environ Res Public Health       Date:  2021-12-14       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.